Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

v3.19.1
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2018
Mar. 06, 2019
Jun. 30, 2018
Document And Entity Information      
Entity Registrant Name GT Biopharma, Inc.    
Entity Central Index Key 0000109657    
Document Type 10-K    
Document Period End Date Dec. 31, 2018    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Is Entity a Well-known Seasoned Issuer? No    
Is Entity a Voluntary Filer? No    
Is Entity's Reporting Status Current? Yes    
Entity Filer Category Non-accelerated Filer    
Entity Emerging Growth Company false    
Entity Small Business true    
Entity Shell Company false    
Entity Public Float     $ 40,400,000
Entity Common Stock, Shares Outstanding   51,374,418  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2018